JANUS HENDERSON GROUP PLC OWNS 5.8% OF JANUX THERAPEUTICS

Company

JANUS HENDERSON GROUP PLC

Filed

February 14, 2022

Accession Number

0001274173-22-000083

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →